According to our results, L1CAM could be a promising target for combination therapy of human melanoma as a knockdown of L1CAM alone already led to a highly significant decrease in metastasis in the xenograft model of human melanoma described in this study even without changes in glycoprotein core-fucosylation by FUT8[12]. The gene discussed is L1CAM; the disease is melanoma.